The Enterprise Value as of November 2024 (TTM) for Akebia Therapeutics, Inc. (AKBA) is 419.45M

According to Akebia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 419.45M. This represents a change of 34.46% compared to the average of 311.95M of the last 4 quarters.

Akebia Therapeutics, Inc. (AKBA) Historical Enterprise Value (quarterly & annually)

How has AKBA Enterprise Value performed in the past?

The mean historical Enterprise Value of Akebia Therapeutics, Inc. over the last ten years is 354.17M. The current 419.45M Enterprise Value has changed 11.74% with respect to the historical average. Over the past ten years (40 quarters), AKBA's Enterprise Value was at its highest in in the June 2020 quarter at 1.72B. The Enterprise Value was at its lowest in in the September 2022 quarter at 14.24M.

Akebia Therapeutics, Inc. (AKBA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Akebia Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Akebia Therapeutics, Inc. (AKBA) Average Enterprise Value

How has AKBA Enterprise Value performed in the past?

The current Enterprise Value of Akebia Therapeutics, Inc. (AKBA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Akebia Therapeutics, Inc. (AKBA) Enterprise Value vs. Peers

How is AKBA’s Enterprise Value compared to its peers?

Akebia Therapeutics, Inc.’s Enterprise Value is greater than Protalix BioTherapeutics, Inc. (102.72M), greater than Cidara Therapeutics, Inc. (20.31M), greater than X4 Pharmaceuticals, Inc. (38.44M), greater than Seres Therapeutics, Inc. (158.02M), greater than AVROBIO, Inc. (-85302404.00), greater than CohBar, Inc. (-4477266.00), greater than Ocean Biomedical, Inc. (35.97M), greater than Enveric Biosciences, Inc. (202.96K), greater than Elevation Oncology, Inc. (18.49M), greater than Hepion Pharmaceuticals, Inc. (5.35M),

Build a custom stock screener for Akebia Therapeutics, Inc. (AKBA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akebia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akebia Therapeutics, Inc. (AKBA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akebia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.